Synergistic glucocorticoids, vitamins, and microbiome strategies for gut protection in critical illness

Abstract

The glucocorticoid receptor (GR) signaling pathway is essential for supporting the integrity of the intestinal barrier, regulating the gut microbiome, and preserving systemic homeostasis in critically ill patients. GR signaling limits bacterial translocation and systemic inflammation by suppressing pro-inflammatory cytokines, reinforcing tight junction proteins, and promoting epithelial renewal. Additionally, physiological levels of glucocorticoids (GCs) stimulate glutamine and proline metabolism, supporting intestinal maturation, with potential clinical relevance. GR signaling modulates inter-organ communication via the gut-lung and gut-brain axes, improving outcomes. Probiotics enhance GC therapy by restoring microbial balance, increasing short-chain fatty acid (SCFA) production, and modulating immune responses. Vitamins A, C, D, and E contribute to gut resilience by stabilizing tight junctions, mitigating oxidative stress, and strengthening mucosal immunity. Specifically, vitamin D balances T-cell subsets and promotes antimicrobial peptides; vitamin C supports collagen synthesis, antioxidant defenses, and immune function; vitamin A promotes immune tolerance and epithelial regeneration; and vitamin E mitigates oxidative damage and excessive cytokine release. GCs, probiotics, and vitamins counteract key drivers of critical illness, including hyperinflammation and dysbiosis, while maintaining strong safety profiles. This integrative approach leverages these interventions’ distinct yet complementary roles to provide a multi-layered defense against gut dysfunction. GCs reduce excessive inflammation and restore immune balance; probiotics enhance microbial diversity and strengthen gut-associated immunity; and vitamins support epithelial integrity and antioxidant defenses. Targeting multiple pathways simultaneously protects the gut barrier and modulates systemic immunity, potentially reducing complications such as sepsis, multiple organ dysfunction syndrome (MODS), and prolonged intensive care unit (ICU) stays. Incorporating these elements into critical care practice offers a novel strategy to mitigate gut dysfunction, reduce systemic inflammation, and enhance immune resilience. This approach may lower infection rates, decrease the incidence of sepsis and MODS, and accelerate recovery by targeting GR signaling, restoring microbial homeostasis, and reinforcing epithelial integrity.

Keywords

Glucocorticoid receptor / critical illness / intestinal barrier / microbiome / glucocorticoid treatment / probiotics / vitamins

References

[1] Soranno DE, Coopersmith CM, Brinkworth JF, Factora FNF, Muntean JH, Mythen MG, et al. A review of gut failure as a cause and consequence of critical illness. Crit Care. 2025; 29: 91.

[2] Grubišić V, Verkhratsky A, Zorec R, Parpura V. Enteric glia regulate gut motility in health and disease. Brain Res Bull. 2018; 136: 109-17.

[3] Rao M, Gulbransen BD. Enteric Glia. Cold Spring Harb Perspect Biol. 2025; 17: a041368.

[4] Zanza C, Romenskaya T, Thangathurai D, Ojetti V, Saviano A, Abenavoli L, et al. Microbiome in Critical Care: An Unconventional and Unknown Ally. Curr Med Chem. 2022; 29: 3179-88.

[5] Yao Y, Cai X, Fei W, Ye Y, Zhao M, Zheng C. The role of short-chain fatty acids in immunity, inflammation and metabolism. Crit Rev Food Sci Nutr. 2022; 62: 1-12.

[6] Liu XF, Shao JH, Liao YT, Wang LN, Jia Y, Dong PJ, et al. Regulation of short-chain fatty acids in the immune system. Front Immunol. 2023; 14: 1186892.

[7] Uebanso T, Shimohata T, Mawatari K, Takahashi A. Functional Roles of B-Vitamins in the Gut and Gut Microbiome. Mol Nutr Food Res. 2020; 64: e2000426.

[8] Otani S, Coopersmith CM. Gut integrity in critical illness. J Intensive Care. 2019; 7: 17.

[9] Al-Sadi R, Ye D, Dokladny K, Ma TY. Mechanism of IL-1beta-induced increase in intestinal epithelial tight junction permeability. J Immunol. 2008; 180: 5653-61.

[10] Luissint AC, Parkos CA, Nusrat A. Inflammation and the Intestinal Barrier: Leukocyte-Epithelial Cell Interactions, Cell Junction Remodeling, and Mucosal Repair. Gastroenterology. 2016; 151: 616-32.

[11] Schlechte J, Zucoloto AZ, Yu IL, Doig CJ, Dunbar MJ, McCoy KD, et al. Dysbiosis of a microbiota-immune metasystem in critical illness is associated with nosocomial infections. Nat Med. 2023; 29: 1017-27.

[12] Reintam Blaser A, Preiser JC, Fruhwald S, Wilmer A, Wernerman J, Benstoem C, et al.; Working Group on Gastrointestinal Function within the Section of Metabolism, Endocrinology and Nutrition (MEN Section) of ESICM. Gastrointestinal dysfunction in the critically ill: a systematic scoping review and research agenda proposed by the Section of Metabolism, Endocrinology and Nutrition of the European Society of Intensive Care Medicine. Crit Care. 2020; 24: 224.

[13] Meduri GU. A paradigm shift: The bidirectional effect of inflammation on bacterial growth. In: Baue AE, Berlot G, Gullo A, Vincent JL, editors. Sepsis and Organ Dysfunction. Milano: Springer; 2000. pp. 145-54.

[14] Kain T, Dionne JC, Marshall JC. Critical illness and the gut microbiome. Intensive Care Med. 2024; 50: 1692-4.

[15] Jeon H, Lee D, Kim JY, Shim JJ, Lee JH. Limosilactobacillus reuteri HY7503 and Its Cellular Proteins Alleviate Endothelial Dysfunction by Increasing Nitric Oxide Production and Regulating Cell Adhesion Molecule Levels. Int J Mol Sci. 2024; 25: 11326.

[16] Naseri A, Seyedi-Sahebari S, Mahmoodpoor A, Sanaie S. Probiotics in Critically Ill Patients: An Umbrella Review. Indian J Crit Care Med. 2022; 26: 339-60.

[17] Muzzi C, Watanabe N, Twomey E, Meers GK, Reichardt HM, Bohnenberger H, et al. The Glucocorticoid Receptor in Intestinal Epithelial Cells Alleviates Colitis and Associated Colorectal Cancer in Mice. Cell Mol Gastroenterol Hepatol. 2021; 11: 1505-18.

[18] Mueller M, Atanasov A, Cima I, Corazza N, Schoonjans K, Brunner T. Differential regulation of glucocorticoid synthesis in murine intestinal epithelial versus adrenocortical cell lines. Endocrinology. 2007; 148: 1445-53.

[19] Kostadinova F, Schwaderer J, Sebeo V, Brunner T. Why does the gut synthesize glucocorticoids? Ann Med. 2014; 46: 490-7.

[20] Noti M, Corazza N, Mueller C, Berger B, Brunner T. TNF suppresses acute intestinal inflammation by inducing local glucocorticoid synthesis. J Exp Med. 2010; 207: 1057-66.

[21] Khadka S, Dziadowicz SA, Xu X, Wang L, Hu G, Carrero JA, et al. Endogenous glucocorticoids are required for normal macrophage activation and gastric Helicobacter pylori immunity. Am J Physiol Gastrointest Liver Physiol. 2024; 327: G531-44.

[22] Leoni G, Alam A, Neumann PA, Lambeth JD, Cheng G, McCoy J, et al. Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. J Clin Invest. 2013; 123: 443-54.

[23] Ma C, Wang F, Zhu J, Wang S, Liu Y, Xu J, et al. 18Beta-Glycyrrhetinic Acid Attenuates H₂O₂-Induced Oxidative Damage and Apoptosis in Intestinal Epithelial Cells via Activating the PI3K/Akt Signaling Pathway. Antioxidants (Basel). 2024; 13: 468.

[24] Meduri GU, Confalonieri M, Chaudhuri D, Rochwerg B, Meibohm B. Chapter 24 - Prolonged glucocorticoid treatment in ARDS: Pathobiological rationale and pharmacological principles. In: Fink G, editor. Stress: Immunology and Inflammation. Academic Press; 2024. pp. 289-324.e1.

[25] Du Y, Rong L, Cong Y, Shen L, Zhang N, Wang B. Macrophage polarization: an effective approach to targeted therapy of inflammatory bowel disease. Expert Opin Ther Targets. 2021; 25: 191-209.

[26] Fischer A, Gluth M, Weege F, Pape UF, Wiedenmann B, Baumgart DC, et al. Glucocorticoids regulate barrier function and claudin expression in intestinal epithelial cells via MKP-1. Am J Physiol Gastrointest Liver Physiol. 2014; 306: G218-28.

[27] Fischer A, Gluth M, Pape UF, Wiedenmann BH, Baumgart DC, Theuring F. 582 Dexamethasone Stimulates Tight Junction Sealing in Intestinal Epithelial Cells by up Regulating Claudin-4 Expression via a Pathway Involving MKP-1 and p38. Gastroenterology. 2010; 138: S-83.

[28] Greenhill C. IBD: Glucocorticoids revealed to augment intestinal epithelial barrier function. Nat Rev Gastroenterol Hepatol. 2024; 11: 75.

[29] Flynn NE, Bird JG, Guthrie AS. Glucocorticoid regulation of amino acid and polyamine metabolism in the small intestine. Amino Acids. 2009; 37: 123-9.

[30] Xu H, Wang Y, Jurutka PW, Wu S, Chen Y, Cao C, et al. 16α-Hydroxytrametenolic Acid from Poria cocos Improves Intestinal Barrier Function Through the Glucocorticoid Receptor-Mediated PI3K/Akt/NF-κB Pathway. J Agric Food Chem. 2019; 67: 10871-9.

[31] Nanthakumar NN, Meng D, Newburg DS. Glucocorticoids and microbiota regulate ontogeny of intestinal fucosyltransferase 2 requisite for gut homeostasis. Glycobiology. 2013; 23: 1131-41.

[32] Ergang P, Vagnerová K, Hermanová P, Vodička M, Jágr M, Šrůtková D, et al. The Gut Microbiota Affects Corticosterone Production in the Murine Small Intestine. Int J Mol Sci. 2021; 22: 4229.

[33] Guo M, Wang H, Xu S, Zhuang Y, An J, Su C, et al. Alteration in gut microbiota is associated with dysregulation of cytokines and glucocorticoid therapy in systemic lupus erythematosus. Gut Microbes. 2020; 11: 1758-73.

[34] Wang Y, Liu F, Zhang G, Su Y, Sun X, Chen Q, et al. Gut microbiome alterations and its link to corticosteroid resistance in immune thrombocytopenia. Sci China Life Sci. 2021; 64: 766-83.

[35] Xie X, Xiao Q, Xiong Z, Yu C, Zhou J, Fu Z. Crocin-I ameliorates the disruption of lipid metabolism and dysbiosis of the gut microbiota induced by chronic corticosterone in mice. Food Funct. 2019; 10: 6779-91.

[36] Su H, Kang Q, Wang H, Yin H, Duan L, Liu Y, et al. Effects of glucocorticoids combined with probiotics in treating Crohn’s disease on inflammatory factors and intestinal microflora. Exp Ther Med. 2018; 16: 2999-3003.

[37] Cui HH, Chen CL, Wang JD, Yang YJ, Cun Y, Wu JB, et al. Effects of probiotic on intestinal mucosa of patients with ulcerative colitis. World J Gastroenterol. 2004; 10: 1521-5.

[38] Huang EY, Inoue T, Leone VA, Dalal S, Touw K, Wang Y, et al. Using corticosteroids to reshape the gut microbiome: implications for inflammatory bowel diseases. Inflamm Bowel Dis. 2015; 21: 963-72.

[39] Schepper J, Rios-Acre N, Collins F, Parameswaran N, McCabe L. Alterations to the Gut Microbiome Prevent Glucocorticoid induced Osteoporosis. FASEB J. 2019; 33: 589.6.

[40] Crouwel F, Buiter HJC, de Boer NK. Gut microbiota-driven drug metabolism in inflammatory bowel disease. J Crohns Colitis. 2020; 15: 307-15.

[41] Meduri GU. Ventilator-associated pneumonia in patients with respiratory failure. A diagnostic approach. Chest. 1990; 97: 1208-19.

[42] Rusch JA, Layden BT, Dugas LR. Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis. Front Endocrinol (Lausanne). 2023; 14: 1130689.

[43] Petra AI, Panagiotidou S, Hatziagelaki E, Stewart JM, Conti P, Theoharides TC. Gut-Microbiota-Brain Axis and Its Effect on Neuropsychiatric Disorders With Suspected Immune Dysregulation. Clin Ther. 2015; 37: 984-95.

[44] Luo Y, Zeng B, Zeng L, Du X, Li B, Huo R, et al. Gut microbiota regulates mouse behaviors through glucocorticoid receptor pathway genes in the hippocampus. Transl Psychiatry. 2018; 8: 187.

[45] Ait-Belgnaoui A, Durand H, Cartier C, Chaumaz G, Eutamene H, Ferrier L, et al. Prevention of gut leakiness by a probiotic treatment leads to attenuated HPA response to an acute psychological stress in rats. Psychoneuroendocrinology. 2012; 37: 1885-95.

[46] Wiley NC, Dinan TG, Ross RP, Stanton C, Clarke G, Cryan JF. The microbiota-gut-brain axis as a key regulator of neural function and the stress response: Implications for human and animal health. J Anim Sci. 2017; 95: 3225-46.

[47] Harms C, Albrecht K, Harms U, Seidel K, Hauck L, Baldinger T, et al. Phosphatidylinositol 3-Akt-kinase-dependent phosphorylation of p21(Waf1/Cip1) as a novel mechanism of neuroprotection by glucocorticoids. J Neurosci. 2007; 27: 4562-71.

[48] Matić G, Milutinović DV, Nestorov J, Elaković I, Jovanović SM, Perišić T, et al. Lymphocyte glucocorticoid receptor expression level and hormone-binding properties differ between war trauma-exposed men with and without PTSD. Prog Neuropsychopharmacol Biol Psychiatry. 2013; 43: 238-45.

[49] Schelling G, Roozendaal B, De Quervain DJ. Can posttraumatic stress disorder be prevented with glucocorticoids? Ann N Y Acad Sci. 2004; 1032: 158-66.

[50] Liu B, Yu Y, Zhao M, Xiao K, Yan P, Duan Z, et al. Correlation Analysis of the Microbiome and Immune Function in the Lung-Gut Axis of Critically Ill Patients in the ICU. Front Med (Lausanne). 2022; 9: 808302.

[51] Nath S, Kitsios GD, Bos LDJ. Gut-lung crosstalk during critical illness. Curr Opin Crit Care. 2023; 29: 130-7.

[52] Dang AT, Marsland BJ. Microbes, metabolites, and the gut-lung axis. Mucosal Immunol. 2019; 12: 843-50.

[53] Tian X, Hellman J, Horswill AR, Crosby HA, Francis KP, Prakash A. Elevated Gut Microbiome-Derived Propionate Levels Are Associated With Reduced Sterile Lung Inflammation and Bacterial Immunity in Mice. Front Microbiol. 2019; 10: 159.

[54] Morris G, Berk M, Carvalho A, Caso JR, Sanz Y, Walder K, et al. The Role of the Microbial Metabolites Including Tryptophan Catabolites and Short Chain Fatty Acids in the Pathophysiology of Immune-Inflammatory and Neuroimmune Disease. Mol Neurobiol. 2017; 54: 4432-51.

[55] Zhang J, Zhu S, Ma N, Johnston LJ, Wu C, Ma X. Metabolites of microbiota response to tryptophan and intestinal mucosal immunity: A therapeutic target to control intestinal inflammation. Med Res Rev. 2021; 41: 1061-88.

[56] Fromentin M, Ricard JD, Roux D. Respiratory microbiome in mechanically ventilated patients: a narrative review. Intensive Care Med. 2021; 47: 292-306.

[57] Ma J, Zhu Z, Yishajiang Y, Alarjani KM, Hong L, Luo L. Role of gut microbiota and inflammatory factors in acute respiratory distress syndrome: a Mendelian randomization analysis. Front Microbiol. 2023; 14: 1294692.

[58] Meduri GU, Muthiah MP, Carratu P, Eltorky M, Chrousos GP. Nuclear factor-kappaB- and glucocorticoid receptor alpha-mediated mechanisms in the regulation of systemic and pulmonary inflammation during sepsis and acute respiratory distress syndrome. Evidence for inflammation-induced target tissue resistance to glucocorticoids. Neuroimmunomodulation. 2005; 12: 321-38.

[59] Meduri GU, Kanangat S, Stefan J, Tolley E, Schaberg D. Cytokines IL-1beta, IL-6, and TNF-alpha enhance in vitro growth of bacteria. Am J Respir Crit Care Med. 1999; 160: 961-7.

[60] Flynn NE, Wu G. Glucocorticoids play an important role in mediating the enhanced metabolism of arginine and glutamine in enterocytes of postweaning pigs. J Nutr. 1997; 127: 732-7.

[61] Ahmadzai MM, Seguella L, Gulbransen BD. Circuit-specific enteric glia regulate intestinal motor neurocircuits. Proc Natl Acad Sci U S A. 2021; 118: e2025938118.

[62] Blin J, Gautier C, Aubert P, Durand T, Oullier T, Aymeric L, et al. Psychological stress induces an increase in cholinergic enteric neuromuscular pathways mediated by glucocorticoid receptors. Front Neurosci. 2023; 17: 1100473.

[63] Binder HJ. Effect of dexamethasone on electrolyte transport in the large intestine of the rat. Gastroenterology. 1978; 75: 212-7.

[64] Meduri GU, Psarra AMG, Amrein K, Chrousos GP. Chapter 23 - General adaptation in critical illness 2: The glucocorticoid signaling system as a master rheostat of homeostatic corrections in concerted action with mitochondrial and essential micronutrient support. In: Fink G, editor. Stress: Immunology and Inflammation. Academic Press; 2024. pp. 263-87.

[65] Fakhoury HMA, Kvietys PR, AlKattan W, Anouti FA, Elahi MA, Karras SN, et al. Vitamin D and intestinal homeostasis: Barrier, microbiota, and immune modulation. J Steroid Biochem Mol Biol. 2020; 200: 105663.

[66] Kellermann L, Jensen KB, Bergenheim F, Gubatan J, Chou ND, Moss A, Nielsen OH. Mucosal vitamin D signaling in inflammatory bowel disease. Autoimmun Rev. 2020; 19: 102672.

[67] Qiu F, Zhang Z, Yang L, Li R, Ma Y. Combined effect of vitamin C and vitamin D₃ on intestinal epithelial barrier by regulating Notch signaling pathway. Nutr Metab (Lond). 2021; 18: 49.

[68] Jo H, Lee D, Go C, Jang Y, Chu N, Bae S, et al. Preventive Effect of Vitamin C on Dextran Sulfate Sodium (DSS)-Induced Colitis via the Regulation of IL-22 and IL-6 Production in Gulo(-/-) Mice. Int J Mol Sci. 2022; 23: 10612.

[69] Carr AC, Maggini S. Vitamin C and Immune Function. Nutrients. 2017; 9: 1211.

[70] Meduri GU. Glucocorticoid receptor alpha: origins and functions of the master regulator of homeostatic corrections in health and critical illness. Explor Endocr Metab Dis. 2025; 2: 101426.

[71] Kaminsky LW, Al-Sadi R, Ma TY. IL-1β and the Intestinal Epithelial Tight Junction Barrier. Front Immunol. 2021; 12: 767456.

[72] Di Tommaso N, Gasbarrini A, Ponziani FR. Intestinal Barrier in Human Health and Disease. Int J Environ Res Public Health. 2021; 18: 12836.

[73] Kurashima Y, Kiyono H. Mucosal Ecological Network of Epithelium and Immune Cells for Gut Homeostasis and Tissue Healing. Annu Rev Immunol. 2017; 35: 119-47.

[74] McCormick TS, Weinberg A. Epithelial cell-derived antimicrobial peptides are multifunctional agents that bridge innate and adaptive immunity. Periodontol 2000. 2010; 54: 195-206.

[75] Schneider S, Wright CM, Heuckeroth RO. Unexpected Roles for the Second Brain: Enteric Nervous System as Master Regulator of Bowel Function. Annu Rev Physiol. 2019; 81: 235-59.

[76] Schemann M. Control of gastrointestinal motility by the “gut brain”--the enteric nervous system. J Pediatr Gastroenterol Nutr. 2005; 41: S4-6.

[77] Chanpong A, Borrelli O, Thapar N. Recent advances in understanding the roles of the enteric nervous system. Fac Rev. 2022; 11: 7.

[78] Di Tommaso N, Santopaolo F, Gasbarrini A, Ponziani FR. The Gut-Vascular Barrier as a New Protagonist in Intestinal and Extraintestinal Diseases. Int J Mol Sci. 2023; 24: 1470.

[79] Varshavskiĭ BIa, Trubnikov GV, Galaktipmpva LP, Koreniak NA, Koledeznaia IL, Oberemok AN. Oxidant-antioxidant status of patients with bronchial asthma during inhalation and systemic glucocorticoid therapy. Ter Arkh. 2003; 75: 21-4. Russian.

[80] Pressley L, Funder JW. Glucocorticoid and mineralocorticoid receptors in gut mucosa. Endocrinology. 1975; 97: 588-96.

[81] Singh P, Sundararajan S, Terranegra A, Elawad M, Akobeng A, Al Khodor S. P927 Corticosteroid treatment in pediatric IBD patients reshapes the gut microbiota. J Crohns Colitis. 2023; 17: i1035-6.

[82] Meduri GU, Chrousos GP. Chapter 22 - General adaptation in critical illness 1: The glucocorticoid signaling system as master rheostat of homeostatic corrections in concerted action with nuclear factor-κB. In: Fink G, editor. Stress: Immunology and Inflammation. Academic Press; 2024. pp. 231-61.

[83] Reichardt SD, Föller M, Rexhepaj R, Pathare G, Minnich K, Tuckermann JP, et al. Glucocorticoids enhance intestinal glucose uptake via the dimerized glucocorticoid receptor in enterocytes. Endocrinology. 2012; 153: 1783-94.

[84] Tena-Garitaonaindia M, Arredondo-Amador M, Mascaraque C, Asensio M, Marin JJG, Martínez-Augustin O, et al. Modulation of intestinal barrier function by glucocorticoids: Lessons from preclinical models. Pharmacol Res. 2022; 177: 106056.

[85] Huang J, Jia R, Brunner T. Local synthesis of immunosuppressive glucocorticoids in the intestinal epithelium regulates anti-viral immune responses. Cell Immunol. 2018; 334: 1-10.

[86] Ahmed A, Schmidt C, Brunner T. Extra-Adrenal Glucocorticoid Synthesis in the Intestinal Mucosa: Between Immune Homeostasis and Immune Escape. Front Immunol. 2019; 10: 1438.

[87] Cantorna MT, Snyder L, Arora J. Vitamin A and vitamin D regulate the microbial complexity, barrier function, and the mucosal immune responses to ensure intestinal homeostasis. Crit Rev Biochem Mol Biol. 2019; 54: 184-92.

[88] Hamza FN, Daher S, Fakhoury HMA, Grant WB, Kvietys PR, Al-Kattan K. Immunomodulatory Properties of Vitamin D in the Intestinal and Respiratory Systems. Nutrients. 2023; 15: 1696.

[89] Audouin-Chevallier I, Pallet V, Coustaut M, Alfos S, Higueret P, Garcin H. Retinoids modulate the binding capacity of the glucocorticoid receptor and its translocation from cytosol to nucleus in liver cells. J Steroid Biochem Mol Biol. 1995; 52: 321-8.

[90] Hammerschmidt SI, Friedrichsen M, Boelter J, Lyszkiewicz M, Kremmer E, Pabst O, et al. Retinoic acid induces homing of protective T and B cells to the gut after subcutaneous immunization in mice. J Clin Invest. 2011; 121: 3051-61.

[91] Liu KY, Nakatsu CH, Jones-Hall Y, Kozik A, Jiang Q. Vitamin E alpha- and gamma-tocopherol mitigate colitis, protect intestinal barrier function and modulate the gut microbiota in mice. Free Radic Biol Med. 2021; 163: 180-9.